Sunshine Biopharma(SBFM) - 2024 Q2 - Quarterly Results

Company Overview - Sunshine Biopharma, Inc. announced its financial results for the period ended June 30, 2024[3]. - The company is registered under the trading symbol SBFM on The Nasdaq Stock Market LLC[1]. - The company is classified as an emerging growth company[2]. - Dr. Steve N. Slilaty serves as the Chief Executive Officer of Sunshine Biopharma, Inc.[4]. Financial Reporting - The press release detailing the financial results was issued on August 19, 2024[3]. - The financial results will not be deemed "filed" under the Securities Exchange Act of 1934[3].